LJPC

La Jolla Pharmaceutical Company

Delisted

LJPC was delisted on the 19th of August, 2022.

73 hedge funds and large institutions have $79.4M invested in La Jolla Pharmaceutical Company in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

13% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 24

18% less call options, than puts

Call options by funds: $464K | Put options by funds: $563K

Holders
73
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$464K
Puts
$563K
Net Calls
Net Calls Change

Top Buyers

1 +$13.2M
2 +$1.08M
3 +$547K
4
BC
Boxer Capital
California
+$486K
5
Two Sigma Investments
Two Sigma Investments
New York
+$306K

Top Sellers

1 -$2.53M
2 -$1.12M
3 -$770K
4
Goldman Sachs
Goldman Sachs
New York
-$762K
5
ARTA
A.R.T. Advisors
New York
-$512K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$33.9M
2
$9.89M
3
$6.52M
4
$5.27M
5
$4.27M
6
$3.74M
7
$2.68M
8
$1.72M
9
$1.32M
10
$1.25M
11
$1.01M
12
$565K
13
$547K
14
$463K
15
$390K
16
$365K
17
$358K
18
$356K
19
$337K
20
$333K
21
$306K
22
$304K
23
$216K
24
$209K
25
$208K